JaeJin An

Has grant

Kaiser Permanente Southern California

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Risk of Severe Morbidity and Mortality of Coronavirus Disease 2019 Among Patients Taking Antihypertensive Medication

Open Date: 2020-06-01

Close Date: 2021-05-31

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Collaborators (7)

Diego R. Mazzotti, Ph.D.

Assistant Professor, Medical Informatics

University of Kansas Medical Center

UNITED STATES

View details

Maria Montez-Rath

Stanford University School of Medicine

UNITED STATES

View details

Michelle C. Odden

UNITED STATES

View details

Manjula Kurella Tamura

Stanford University School of Medicine

UNITED STATES

View details

Leila Zelnick

Research Assistant Professor

University of Washington

UNITED STATES

View details

Amy Sawyer

Associate Professor of Sleep & Health Behavior

University of Pennsylvania

UNITED STATES

View details

Nisha Bansal

Associate Professor

University of Washington

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

JaeJin An

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (18)

Association of Rate‐Control and Antiarrhythmic Medication Use and Risk of Ischemic Stroke and Death in Patients on Dialysis With Atrial Fibrillation

Clinical and Demographic Characteristics Associated With Diabetes Remission in Six Integrated Health Care Systems: A Retrospective Cohort Study

Development and Validation of an Incident Hypertension Risk Prediction Model for Young Adults

Clinical and socioeconomic factors associated with recurrent atrial fibrillation after catheter ablation or antiarrhythmic drug therapy

Representation of Real‐World Adults With Chronic Kidney Disease in Clinical Trials Supporting Blood Pressure Treatment Targets

Blood Pressure Reduction and Changes in Antihypertensive Medication Use Among Patients With Hypertension Who Initiated Sodium‐Glucose Cotransporter‐2 Inhibitors

Risk-enhancing factors and social determinants of health in risk assessment for atherosclerotic cardiovascular disease

Trends in Initial Antihypertensive Medication Prescribing Among >2.8 Million Veterans Newly Diagnosed With Hypertension, 2000 to 2019

Association Between Young Adult Characteristics and Blood Pressure Trajectories

Incident Atrial Fibrillation and Risk of Dementia in a Diverse, Community‐Based Population

Association of Kidney Function With Risk of Adverse Effects of Therapies for Atrial Fibrillation

Treatment and Control of Hypertension Among Adults With Chronic Kidney Disease, 2011 to 2019

Effectiveness and safety of Dabigatran 110 mg versus 150 mg for Stroke Prevention in Patients with Atrial Fibrillation at High Bleeding Risk

Association Between Positive Airway Pressure Adherence and Health Care Costs Among Individuals With OSA

Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors Secondary to Hyperkalemia Translates into Higher Cardiorenal Outcomes

Incidence of Atherosclerotic Cardiovascular Disease in Young Adults at Low Short-Term But High Long-Term Risk

Prevalence of Apparent Treatment-Resistant Hypertension in Chronic Kidney Disease in Two Large US Health Care Systems

Cardiovascular and kidney outcomes of spironolactone or eplerenone in combination with ACEI/ARBs in patients with diabetic kidney disease

Collaborators (7)

Diego R. Mazzotti, Ph.D.

Maria Montez-Rath

Michelle C. Odden

Manjula Kurella Tamura

Leila Zelnick

Amy Sawyer

Nisha Bansal

Make your next move.